A randomized, open‐label pharmacokinetic trial of tacrolimus extended‐release dosing in obese de novo kidney transplant recipients

Open Label

De novo low-dose sirolimus versus mycophenolate mofetil in combination with extended-release tacrolimus in kidney transplant recipients: a multicentre, open-label, randomized, controlled, non-inferiority trial

Nephrology Dialysis Transplantation ◽

10.1093/ndt/gfx093 ◽

2017 ◽

Vol 32 (8) ◽

pp. 1415-1424 ◽

Cited By ~ 6

Author(s):

Kyu Ha Huh ◽

Jae Geun Lee ◽

Jongwon Ha ◽

Chang-Kwon Oh ◽

Man Ki Ju ◽

...

Keyword(s):

Mycophenolate Mofetil ◽

Kidney Transplant ◽

Extended Release ◽

Low Dose ◽

De Novo ◽

Transplant Recipients ◽

Open Label ◽

Randomized Controlled

SP653COMPARISON OF LOW DOSE AND VERY LOW DOSE EXTENDED-RELEASE TACROLIMUS / MMF IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS

Nephrology Dialysis Transplantation ◽

10.1093/ndt/gfw178.12 ◽

2016 ◽

Vol 31 (suppl_1) ◽

pp. i312-i312

Author(s):

Shunji Narumi ◽

Yoshihiko Watarai ◽

Norihiko Goto ◽

Takahisa Hiramitsu ◽

Takayuki Yamamoto ◽

...

Keyword(s):

Kidney Transplant ◽

Extended Release ◽

Low Dose ◽

De Novo ◽

Transplant Recipients ◽

Kidney Transplant Recipients

Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial

American Journal of Kidney Diseases ◽

10.1053/j.ajkd.2015.10.024 ◽

2016 ◽

Vol 67 (4) ◽

pp. 648-659 ◽

Cited By ~ 42

Author(s):

Lionel Rostaing ◽

Suphamai Bunnapradist ◽

Josep M. Grinyó ◽

Kazimierz Ciechanowski ◽

Jason E. Denny ◽

...

Keyword(s):

Randomized Trial ◽

Kidney Transplant ◽

Extended Release ◽

De Novo ◽

Transplant Recipients ◽

Phase 3 ◽

Double Blind ◽

Once Daily

A 3-month, Multicenter, Randomized, Open-label Study to Evaluate the Impact on Wound Healing of the Early (vs Delayed) Introduction of Everolimus in De Novo Kidney Transplant Recipients, With a Follow-up Evaluation at 12 Months After Transplant (NEVERWOUND Study)

10.1097/tp.0000000000002851 ◽

2020 ◽

Vol 104 (2) ◽

pp. 374-386 ◽

Cited By ~ 1

Author(s):

Tommaso Maria Manzia ◽

Mario Carmellini ◽

Paola Todeschini ◽

Antonio Secchi ◽

Silvio Sandrini ◽

...

Keyword(s):

Wound Healing ◽

Kidney Transplant ◽

De Novo ◽

Transplant Recipients ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

The Impact

Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study

Advances in Therapy ◽

10.1007/s12325-018-0855-1 ◽

2018 ◽

Vol 36 (2) ◽

pp. 462-477 ◽

Cited By ~ 4

Author(s):

Nassim Kamar ◽

Elisabeth Cassuto ◽

Giovanni Piotti ◽

Mirco Govoni ◽

Giorgia Ciurlia ◽

...

Keyword(s):

Kidney Transplant ◽

Multicenter Study ◽

De Novo ◽

Prolonged Release ◽

Transplant Recipients ◽

Open Label ◽

Once Daily ◽

Parallel Group

A PHASE 2, RANDOMIZED, OPEN-LABEL, PARALLEL GROUP, MULTI-CENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF TACROLIMUS/FK778 AND TACROLIMUS/MMF IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS.

10.1097/00007890-200607152-01088 ◽

2006 ◽

Vol 82 (Suppl 2) ◽

pp. 433

Author(s):

&NA;

Keyword(s):

Kidney Transplant ◽

De Novo ◽

Phase 2 ◽

Transplant Recipients ◽

Open Label ◽

Safety And Efficacy ◽

Parallel Group ◽

Multi Center Study ◽

Center Study

A PHASE III, RANDOMIZED, OPEN-LABEL, COMPARATIVE, MULTI-CENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF PROGRAF?? (TACROLIMUS)/MMF, MODIFIED RELEASE (MR) TACROLIMUS/MMF AND NEORAL?? (CYCLOSPORINE)/MMF IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: 12 MONTH RESULTS.

10.1097/00007890-200607152-00748 ◽

2006 ◽

Vol 82 (Suppl 2) ◽

pp. 318

Author(s):

&NA;

Keyword(s):

Kidney Transplant ◽

De Novo ◽

Phase Iii ◽

Modified Release ◽

Transplant Recipients ◽

Open Label ◽

Safety And Efficacy ◽

Multi Center Study ◽

Center Study

One-Year Results with Extended-Release Tacrolimus/MMF, Tacrolimus/MMF and Cyclosporine/MMF in De Novo Kidney Transplant Recipients

American Journal of Transplantation ◽

10.1111/j.1600-6143.2007.01661.x ◽

2007 ◽

Vol 7 (3) ◽

pp. 595-608 ◽

Cited By ~ 142

Author(s):

H. T. Silva ◽

H. C. Yang ◽

M. Abouljoud ◽

P. C. Kuo ◽

K. Wisemandle ◽

...

Keyword(s):

Kidney Transplant ◽

Extended Release ◽

De Novo ◽

Transplant Recipients ◽

One Year

Extended-Release Tacrolimus Therapy in De Novo Kidney Transplant Recipients: Single-Center Experience

Transplantation Proceedings ◽

10.1016/j.transproceed.2010.07.044 ◽

2010 ◽

Vol 42 (8) ◽

pp. 3034-3037 ◽

Cited By ~ 12

Author(s):

A. Andrés ◽

M. Delgado-Arranz ◽

E. Morales ◽

T. Dipalma ◽

N. Polanco ◽

...

Keyword(s):

Kidney Transplant ◽

Extended Release ◽

De Novo ◽

Transplant Recipients ◽

Single Center ◽

Single Center Experience ◽

Tacrolimus Therapy

INTENSIFIED DOSE OF ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) FOR 6 WEEKS, IN COMBINATION WITH ANTI-IL2R INDUCTION, CYCLOSPORINE MICRO-EMULSION (CSA-ME) WITH OR WITHOUT STEROIDS, IN ADULT DE NOVO LOW IMMUNOLOGICAL RISK KIDNEY TRANSPLANT RECIPIENTS: FINAL EFFICACY AND SAFETY RESULTS OF A PROSPECTIVE MULTICENTER RANDOMIZED OPEN-LABEL STUDY: DOMINOS STUDY.

10.1097/00007890-201007272-00215 ◽

2010 ◽

Vol 90 ◽

pp. 111

Author(s):

G. Touchard ◽

Y. Lebranchu ◽

G. Mourad ◽

L. Rostaing ◽

S. Quere ◽

...

Keyword(s):

Kidney Transplant ◽

De Novo ◽

Efficacy And Safety ◽

Transplant Recipients ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Micro Emulsion ◽

Enteric Coated